Citalopram No Better Than Placebo Treatment for Children with Autism Spectrum Disorders – 2
Narrator: This is NIH Health Matters. According to a study funded by the National Institute of Mental Health, a drug called citalopram works no better than a placebo at reducing repetitive behaviors in children with autism spectrum disorders. Dr. Bryan King is with the University of Washington and Seattle Childrenís Hospital.
Dr. King: We certainly didnít find any evidence to support the effectiveness of this medicine for this particular indication.
Narrator: In the study, a placebo, an inactive substance, was given to one group, while citalopram was given to a similar group; then the results were compared. For details on the study, visit www.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.